A 9ha ready-built, best-in-class pharmaceutical manufacturing plant at 21 Tuas South Avenue 6 is up for sale at an indicative price of $90 million.
The property sits on approximately 935,341 sq ft of land and offers a total gross floor area (GFA) of 397,387 sq ft. With a plot ratio of 1.0, the site provides approximately 535,000 sq ft of untapped GFA, supported by a significant greenfield land parcel at the rear of the facility, ready for immediate expansion, according to exclusive marketing agent Cushman & Wakefield.
The property has 32 years remaining on its tenure with “nominal” annual land rent payable, says Cushman & Wakefield — a “standout advantage” compared to most industrial leases from JTC, where shorter 20- to 30-year leases are the norm.
Located in Tuas Biomedical Park, the facility sits at the nexus of biomedical research and manufacturing, fostering synergies with leading biopharmaceutical companies and research institutes.
It is also just minutes from the upcoming Tuas Mega Port, providing seamless connectivity and efficient global distribution for pharmaceutical products, which are typically temperature-sensitive.
Brenda Ong, executive director, logistics and industrial at Cushman & Wakefield, says the property presents a “rare opportunity” for occupiers to acquire a “plug-and-play facility” with “top-tier specifications”. “Located within Tuas Biomedical Park and in close proximity to the future Tuas Mega Port, the site offers strong potential for future expansion or redevelopment, enabling occupiers to scale operations while benefiting from synergies with other pharmaceutical players and enhanced supply chain efficiencies.”
See also: Tuas mega-site changes hands for $322 mil in Singapore’s largest private industrial land deal
According to Cushman & Wakefield, Singapore remains a highly attractive destination for pharmaceutical and biotechnology companies looking to establish or expand their operations.
Total fixed asset investments in the biomedical manufacturing sector have increased steadily since 2022, nearly doubling y-o-y to reach a record high of $4.4 billion in 2025.
Growth momentum is expected to persist, supported by continued government backing through the Research, Innovation and Enterprise (RIE) 2030 Plan, alongside structural megatrends such as an ageing population driving healthcare demand, says Cushman & Wakefield.
See also: $1 bil ‘well-being destination’ Therme Singapore breaks ground at Marina South
Reflecting these positive fundamentals, the single-user factory segment recorded cumulative rental and price growth of 20.1% and 20.3% respectively over the past five years (1Q2021 to 4Q2025).
The property is available for sale via private treaty.
In April, Far East Organization sold four single-storey warehouse units at 10, 20, 30 and 40 Tuas South Street 1 for $322 million in Singapore’s largest private industrial land deal.
